周三盘后交易中，欧普科健康（Opko Health，股票代码：OPK）股价大跌5.80%，主要原因是公司公布的第一季度财报未达市场预期。
根据欧普科健康发布的财报显示，截至3月31日的季度调整后每股亏损为0.10美元，高于分析师平均预期的0.07美元亏损。公司营收同比下降13.7%至1.499亿美元，同样低于分析师预期的1.6426亿美元。此外，欧普科健康本季度净亏损达6760万美元，显示公司面临严峻的经营挑战。
尽管财报表现不佳，但华尔街分析师对欧普科健康仍保持相对乐观态度。目前，分析师对该公司股票的平均评级为"买入"，其中6个为"强烈买入"或"买入"，1个为"持有"，没有"卖出"或"强烈卖出"评级。分析师给出的12个月目标价中位数为3.00美元。然而，投资者应注意，公司股价今年迄今已下跌4.8%，本季度更是下跌了15.7%，反映出市场对公司业绩的担忧情绪。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.